GO:0016104 triterpenoid biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016104 describes the biosynthesis of triterpenoids, a large class of natural products built from six isoprene units [1, 2].
• The pathway proceeds through cyclization of 2,3-oxidosqualene into diverse triterpene skeletons, followed by tailoring reactions such as oxidation and glycosylation [1, 4, 8].
• Key enzymes include oxidosqualene cyclases, cytochrome P450s, and UDP-glycosyltransferases that generate bioactive triterpenoid saponins and withanolides [1, 2, 8].
• Triterpenoids have pharmaceutical potential in osteoporosis, cancer, and antifungal applications [3, 6, 7].
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of triterpenoid biosynthetic genes [1, 4, 8].
• Studying this pathway supports metabolic engineering and synthetic biology for sustainable production of high-value triterpenoids [1, 4].
Description
Triterpenoids are a structurally diverse group of natural products derived from the cyclization of 2,3-oxidosqualene, a reaction that generates the initial 30-carbon triterpene skeleton [1, 4]. The Gene Ontology term GO:0016104, triterpenoid biosynthetic process, encompasses all chemical reactions and pathways leading to these compounds, which are built from six isoprene units [1, 2]. This process is central to plant, fungal, and some bacterial secondary metabolism and yields molecules with important ecological and pharmacological roles [2, 8]. Researchers study triterpenoid biosynthesis to understand how plants and fungi produce bioactive compounds such as saponins, withanolides, and lanostane-type triterpenoids [1, 4, 8]. The pathway is also a target for metabolic engineering because many triterpenoids have demonstrated therapeutic potential, including anti-osteoporotic and anticancer activities [3, 6]. Recent advances in total biosynthesis and combinatorial biosynthesis have enabled the production of complex triterpenoids in heterologous systems, highlighting the importance of identifying and characterizing the enzymes involved [1, 7]. This article provides a research-grade overview of GO:0016104, covering its definition, molecular mechanisms, key genes, disease relevance, and experimental approaches including CRISPR-based models.
triterpenoid biosynthetic process At A Glance
| GO ID | GO:0016104 |
|---|---|
| GO term | triterpenoid biosynthetic process |
| Ontology | biological_process |
| Synonym | triterpene biosynthesis; triterpene biosynthetic process; triterpenoid anabolism; triterpenoid biosynthesis; triterpenoid formation; triterpenoid synthesis |
| Major function | Biosynthesis of triterpenoid compounds from six isoprene units |
| Key starting substrate | 2,3-oxidosqualene |
| Representative enzymes | Oxidosqualene cyclases, cytochrome P450s, UDP-glycosyltransferases |
| Pathway end products | Triterpenoid saponins, withanolides, lanostane-type triterpenoids |
What Is GO:0016104?
GO:0016104, triterpenoid biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of triterpenoid compounds, which are terpenoids containing six isoprene units [1, 2]. This process includes the cyclization of 2,3-oxidosqualene to form diverse triterpene skeletons and subsequent enzymatic modifications such as oxidation, glycosylation, and acylation that generate the final bioactive triterpenoids [1, 4, 8].
Why Is triterpenoid biosynthetic process Important in Cell Biology?
Triterpenoid biosynthetic process is important because it produces a vast array of natural products with significant pharmaceutical, agricultural, and biotechnological value [1, 2, 8]. Many triterpenoids exhibit anticancer, anti-osteoporotic, antifungal, and immunomodulatory activities, making the pathway a rich source of drug leads and nutraceuticals [3, 6, 7]. Understanding the enzymes and regulatory mechanisms of this pathway enables metabolic engineering and synthetic biology approaches to produce high-value compounds sustainably [1, 4, 7].
• Provides the biosynthetic route to clinically relevant triterpenoid saponins such as astragalosides.
• Generates withanolides, which have anticancer and adaptogenic properties.
• Produces lanostane-type triterpenoids with medicinal value from Antrodia camphorata.
• Yields antifungal compounds like polytolypin that can be optimized via combinatorial biosynthesis.
• Supports the development of anti-osteoporotic agents, as shown for a triterpenoid saponin from Pimpinella candolleana.
• Contributes to the understanding of UDP-glycosyltransferases that diversify triterpenoid structures.
• Enables the total biosynthesis of complex triterpenoids in heterologous hosts.
• Offers targets for CRISPR-based functional genomics to dissect gene function [1, 4, 8].
• Facilitates the discovery of novel triterpenoid-based therapeutics, including nucleoside transport inhibitors.
• Advances sustainable production of bioactive triterpenoids through metabolic engineering [1, 4].
What Happens During triterpenoid biosynthetic process?
Formation of the triterpene skeleton
In simple terms: The pathway starts by folding a linear molecule into a ring structure.
The committed step in triterpenoid biosynthesis is the cyclization of 2,3-oxidosqualene by oxidosqualene cyclases to form diverse triterpene skeletons such as lanosterol, cycloartenol, or dammarenediol [1, 4, 8]. This reaction generates the characteristic six-isoprene-unit carbon framework and sets the stage for further modifications [1, 2].
Oxidative tailoring by cytochrome P450s
In simple terms: Enzymes add oxygen atoms to the skeleton to make it more reactive.
After cyclization, cytochrome P450 monooxygenases catalyze regio- and stereospecific oxidations, including hydroxylation and epoxidation, that decorate the triterpene core [1, 4, 8]. These modifications are essential for the bioactivity of many triterpenoids, such as the withanolides in Withania somnifera.
Glycosylation and other conjugations
In simple terms: Sugar molecules are attached to the triterpene to increase solubility and diversity.
UDP-glycosyltransferases transfer sugar moieties from UDP-sugars to triterpene aglycones, producing triterpenoid saponins [1, 2]. This glycosylation step is critical for the pharmacological properties of compounds like astragalosides and the anti-osteoporotic saponin from Pimpinella candolleana [1, 6].
Post-modification in fungal systems
In simple terms: Fungi use similar but distinct enzymes to modify triterpenoids.
In the medicinal mushroom Antrodia camphorata, lanostane-type triterpenoids undergo post-modifications catalyzed by specific enzymes, including cytochrome P450s and glycosyltransferases, that contribute to their structural diversity and bioactivity.
Combinatorial biosynthesis for novel analogues
In simple terms: Mixing enzymes from different pathways can create new triterpenoid variants.
Combinatorial biosynthesis, which combines enzymes from different triterpenoid pathways, has been used to generate new analogues of the antifungal fernane-type triterpenoid polytolypin. This approach leverages the promiscuity of tailoring enzymes to expand chemical diversity.
Key Genes Involved in GO:0016104 triterpenoid biosynthetic process
The following genes and proteins are representative of the triterpenoid biosynthetic process, based on published literature [1, 2, 4, 7, 8].
| Gene | Major Role | Research Relevance |
|---|---|---|
| OSC1 | Oxidosqualene cyclase that forms the triterpene skeleton | Target for knockout to block triterpenoid production |
| CYP716A | Cytochrome P450 catalyzing oxidative tailoring | Key for generating bioactive triterpenoids |
| UGT73 | UDP-glycosyltransferase that glycosylates triterpenes | Determines saponin diversity and solubility |
| UGT74 | UDP-glycosyltransferase involved in triterpenoid saponin biosynthesis | Potential target for engineering glycosylation patterns |
| CYP512 | Cytochrome P450 in lanostane triterpenoid modification | Important for Antrodia camphorata triterpenoid biosynthesis |
| CYP514 | Cytochrome P450 in lanostane triterpenoid modification | Contributes to post-modification steps |
| UGT1 | Glycosyltransferase in lanostane triterpenoid pathway | Involved in final triterpenoid maturation |
| CAS1 | Cycloartenol synthase | Model enzyme for triterpene cyclization studies |
| LAS1 | Lanosterol synthase | Fungal triterpenoid biosynthesis |
| DDS | Dammarenediol synthase | Withanolide biosynthesis in Withania somnifera |
| CYP710 | Cytochrome P450 in withanolide biosynthesis | Tailoring enzyme for withanolides |
| GT1 | Glycosyltransferase in withanolide pathway | Modifies withanolide aglycones |
| PTL1 | Enzyme involved in polytolypin biosynthesis | Target for combinatorial biosynthesis |
| PTL2 | Enzyme involved in polytolypin biosynthesis | Generates new analogues |
| CYP93 | Cytochrome P450 in triterpenoid saponin biosynthesis | Potential for metabolic engineering |
| UGT71 | UDP-glycosyltransferase in triterpenoid saponin biosynthesis | Diversifies saponin structures |
| CYP705 | Cytochrome P450 in triterpenoid biosynthesis | Contributes to oxidative modifications |
| UGT94 | UDP-glycosyltransferase in triterpenoid biosynthesis | Involved in saponin production |
How Is triterpenoid biosynthetic process Regulated?
The triterpenoid biosynthetic process is regulated at multiple levels, including transcriptional control of biosynthetic genes, post-translational modification of enzymes, and feedback inhibition by end products [1, 2, 8]. In plants, jasmonate signaling often induces triterpenoid biosynthesis in response to stress or herbivory. In fungi, the expression of lanostane triterpenoid biosynthetic genes can be influenced by culture conditions and developmental stages. Additionally, the availability of substrates such as 2,3-oxidosqualene and UDP-sugars can limit flux through the pathway [1, 2].
triterpenoid biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP716A | Osteoporosis (osteogenesis promotion) | Knockout in osteoblast cell lines |
| UGT73 | Cancer (chemoresistance modulation) | Overexpression in cancer cell lines |
| OSC1 | Antifungal compound production | Knockout in fungal strains |
| CYP512 | Fungal triterpenoid bioactivity | Point mutation in Antrodia camphorata |
| DDS | Withanolide biosynthesis | Knock-in in Withania somnifera |
Triterpenoids in osteoporosis
A novel triterpenoid saponin from Pimpinella candolleana alleviates postmenopausal osteoporosis by promoting osteogenesis via P38/JNK MAPK signaling. This highlights the potential of triterpenoid biosynthetic products as therapeutic agents for bone diseases.
Triterpenoids in cancer
Cimicifugoside, a triterpenoid from Cimicifuga simplex, inhibits nucleoside transport and synergistically potentiates methotrexate cytotoxicity, suggesting a role in cancer chemotherapy. Other triterpenoids, such as withanolides, have demonstrated anticancer activities.
Triterpenoids as antifungals
The fernane-type triterpenoid polytolypin exhibits antifungal activity, and combinatorial biosynthesis has been used to generate new analogues with potentially improved properties. This underscores the relevance of triterpenoid biosynthesis in developing antifungal agents.
Triterpenoids in metabolic engineering
Total biosynthesis of astragalosides in heterologous systems demonstrates the potential of engineering the triterpenoid biosynthetic pathway for sustainable production of medicinal compounds. This approach can be applied to produce other high-value triterpenoids [1, 4].
From triterpenoid biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of OSC1 abolish triterpenoid production? | CRISPR knockout in plant or fungal cells [1, 4] |
| Can a point mutation in CYP716A alter substrate specificity? | CRISPR point mutation in heterologous expression system |
| Can knock-in of UGT73 enhance saponin glycosylation? | CRISPR knock-in in plant cells |
| Does overexpression of DDS increase withanolide yield? | CRISPR overexpression in Withania somnifera |
| Can combinatorial biosynthesis generate new polytolypin analogues? | CRISPR-mediated gene replacement in fungi |
| Does tagged knock-in of CYP512 affect enzyme localization? | CRISPR tagged knock-in in Antrodia camphorata |
How to Study the triterpenoid biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS | Triterpenoid profiles and quantities | Metabolic profiling of plant/fungal extracts [1, 4] |
| RNA-seq | Gene expression levels | Identifying biosynthetic gene clusters |
| Heterologous expression | Enzyme activity and substrate specificity | Characterizing OSC and UGT enzymes [1, 2] |
| CRISPR knockout | Loss-of-function phenotype | Testing essentiality of biosynthetic genes [1, 4] |
| CRISPR knock-in | Gain-of-function or tagging | Studying enzyme localization |
| CRISPR overexpression | Increased pathway flux | Enhancing triterpenoid yield |
| Combinatorial biosynthesis | Novel compound generation | Producing new triterpenoid analogues |
| Phylogenetic analysis | Evolutionary relationships of enzymes | Guiding enzyme selection for engineering |
Metabolomics and LC-MS
Liquid chromatography-mass spectrometry (LC-MS) is widely used to profile triterpenoid compounds and quantify pathway intermediates and end products [1, 4, 8]. This method enables the detection of saponins, withanolides, and lanostane-type triterpenoids in complex biological samples [1, 4].
Transcriptomics and RNA-seq
RNA sequencing can identify co-expressed gene clusters involved in triterpenoid biosynthesis, as demonstrated in Withania somnifera and Antrodia camphorata [4, 8]. Differential expression analysis helps pinpoint candidate biosynthetic genes for functional characterization.
Heterologous expression and enzyme assays
Recombinant expression of candidate enzymes in yeast or E. coli followed by in vitro enzyme assays is a standard approach to confirm catalytic activity and substrate specificity [1, 7]. This method has been used to characterize oxidosqualene cyclases and glycosyltransferases [1, 2].
CRISPR-based functional genomics
CRISPR knockout, knock-in, and overexpression models allow causal testing of gene function in triterpenoid biosynthesis [1, 4, 8]. These approaches can be combined with metabolomics to link genotype to triterpenoid profile [1, 4].
How CRISPR Can Be Used to Study GO:0016104 triterpenoid biosynthetic process
Knockout
CRISPR knockout of triterpenoid biosynthetic genes such as OSC1 or CYP716A can abolish or reduce the production of specific triterpenoids, providing direct evidence of their function [1, 4]. This approach is valuable for validating essential enzymes in the pathway.
Point Mutation
CRISPR point mutation can be used to alter catalytic residues in enzymes like cytochrome P450s, enabling structure-function studies and tuning of substrate specificity. Such models help dissect the contribution of individual amino acids to triterpenoid biosynthesis.
Knock-in
CRISPR knock-in of glycosyltransferase genes or tags can modify triterpenoid glycosylation patterns or facilitate enzyme tracking [2, 4]. This approach is useful for engineering novel triterpenoid saponins.
Overexpression
CRISPR-mediated overexpression of rate-limiting enzymes such as DDS or UGTs can increase flux through the triterpenoid pathway and enhance yields of target compounds. This strategy is commonly used in metabolic engineering [1, 8].
How EDITGENE Supports triterpenoid biosynthetic process Research
Researchers studying triterpenoid biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in the pathway, which requires precise genome editing and functional validation. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for triterpenoid biosynthetic process research.
Frequently Asked Questions About triterpenoid biosynthetic process
What is GO:0016104 triterpenoid biosynthetic process?
GO:0016104 is a Gene Ontology term describing the chemical reactions and pathways that produce triterpenoids, terpenoids with six isoprene units [1, 2].
What genes are involved in triterpenoid biosynthetic process?
Key genes include oxidosqualene cyclases (OSC1), cytochrome P450s (CYP716A, CYP512), and UDP-glycosyltransferases (UGT73, UGT74) [1, 2, 4].
What are the main steps of triterpenoid biosynthesis?
The pathway involves cyclization of 2,3-oxidosqualene, oxidative tailoring by P450s, and glycosylation by UGTs [1, 2, 8].
Why is triterpenoid biosynthetic process important for medicine?
It produces bioactive compounds with anticancer, anti-osteoporotic, and antifungal activities [3, 6, 7].
How can CRISPR be used to study triterpenoid biosynthesis?
CRISPR knockout, knock-in, and overexpression allow functional validation of biosynthetic genes and pathway engineering [1, 4, 8].
What are triterpenoid saponins?
Triterpenoid saponins are glycosylated triterpenoids produced by UDP-glycosyltransferases, with diverse pharmacological activities [1, 2].
Which organisms produce triterpenoids?
Plants, fungi, and some bacteria produce triterpenoids, including Withania somnifera and Antrodia camphorata [4, 8].
What is the role of oxidosqualene cyclase in triterpenoid biosynthesis?
Oxidosqualene cyclase catalyzes the committed cyclization step to form the triterpene skeleton [1, 4].
How are triterpenoids used in osteoporosis research?
A triterpenoid saponin from Pimpinella candolleana alleviates postmenopausal osteoporosis via P38/JNK MAPK signaling.
What methods are used to study triterpenoid biosynthesis?
LC-MS, RNA-seq, heterologous expression, and CRISPR-based functional genomics are commonly used [1, 4, 8].
Conclusion
GO:0016104 triterpenoid biosynthetic process is a fundamental biological pathway that generates a vast array of bioactive natural products with significant pharmaceutical and biotechnological value [1, 2, 8]. Understanding its molecular mechanisms, key enzymes, and regulation is essential for metabolic engineering and drug discovery [1, 4, 7]. CRISPR-based models provide powerful tools to dissect gene function and accelerate the development of triterpenoid-based therapeutics [1, 4, 8].
References
- 1. Xu B et al.. 2024. Total biosynthesis of the medicinal triterpenoid saponin astragalosides.. Nat Plants 10(11):1826-1837 PMID: 39433972
- 2. Rahimi S et al.. 2019. Triterpenoid-biosynthetic UDP-glycosyltransferases from plants.. Biotechnol Adv 37(7):107394 PMID: 31078628
- 3. Yawata A et al.. 2009. Inhibition of nucleoside transport and synergistic potentiation of methotrexate cytotoxicity by cimicifugoside, a triterpenoid from Cimicifuga simplex.. Eur J Pharm Sci 38(4):355-61 PMID: 19748575
- 4. Zhang YQ et al.. 2025. Identification of Key Post‐modification Enzymes Involved in the Biosynthesis of Lanostane‐type Triterpenoids in the Medicinal Mushroom Antrodia camphorata.. Angew Chem Int Ed Engl 64(7):e202420104 PMID: 39617723
- 6. Wu J et al.. 2025. A novel triterpenoid saponin from Pimpinella candolleana alleviates postmenopausal osteoporosis via P38/JNK MAPK-mediated osteogenesis.. Phytomedicine 145:157004 PMID: 40609388
- 7. Li XY et al.. 2023. Biosynthetic characterization of the antifungal fernane-type triterpenoid polytolypin for generation of new analogues via combinatorial biosynthesis.. Org Biomol Chem 21(4):851-857 PMID: 36602159
- 8. Narayanan AK et al.. 2024. Biosynthesis of the triterpenoid withanolides in Withaniasomnifera.. Curr Opin Plant Biol 81:102576 PMID: 38878523
